niga-ichigoside F1

RN given for (2alpha,3beta,4alpha)-isomer

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Non-alcoholic Fatty Liver Disease 02/21/2018 - "Thus, we hypothesized that antihyperlipidemic and antioxidant activities of niga-ichigoside F1 (NI) would ameliorate events leading to NAFLD. "
2.	Inflammation (Inflammations) 09/19/2023 - "A total of nine compounds were identified, including 1-O-E-cinnamoyl-(6-arabinosylglucose), ellagic acid-O-rhamnoside, (epi) catechin, niga-ichigoside F1, etc. The results demonstrated that RSE ameliorated DSS-induced inflammation in mouse colon tissues by increasing mucin expression, reducing the production of TNF-α, IL-1β, and IL-6, inhibiting the mRNA expression of COX-2 and iNOS, regulating the composition of gut microbiota through suppressing Escherichia-Shigella while increasing Akkermansia muciniphila, and promoting the production of SCFAs, especially acetic acid. "
3.	Rheumatoid Arthritis 05/01/2006 - "The triterpenoid glycoside niga-ichigoside F1 (NIF1) and its aglycone 23-hydroxytormentic acid (23-HTA), which were isolated from the unripe fruits of Rubus coreanus (Rosaceae), reduced rheumatoid arthritis (RA) factor and C-reactive protein (CRP) factor in Freund's complete adjuvant reagent-induced rats, suggesting that these two triterpenoids had an anti-rheumatic effect. "

1.	Acetic Acid (Vinegar)
2.	Interleukin-6 (Interleukin 6)
3.	Triterpenes
4.	Messenger RNA (mRNA)
5.	Mucins
6.	Indicators and Reagents (Reagents)
7.	Glycosides
8.	Ellagic Acid
9.	Catechin (Z 7300)
10.	C-Reactive Protein